Zhuoran Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhuoran Cao has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Bin Hu
Department of Gastroenterology, Shanghai Key Laboratory of Pancreatic Disease, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
19 shared publications - Chen Huang
Department of Gastrointestinal Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
19 shared publications - Da Qin
Precision Research Center for Refractory Diseases, Shanghai Jiao Tong University Pioneer Research Institute for Molecular and Cell Therapies, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
19 shared publications - Jing Mei
Precision Research Center for Refractory Diseases, Shanghai Jiao Tong University Pioneer Research Institute for Molecular and Cell Therapies, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
19 shared publications - Jinyan Zhang
Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, shanghai, China
19 shared publications - Junming Xu
Department of General Surgery, Shanghai General Hospital of Nanjing Medical University, Shanghai, 200080, China; Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China
19 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 promotes colorectal cancer cell growth and enhances 5-FU chemotherapeutic efficacy
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 promotes colorectal cancer cell growth and enhances 5-FU chemotherapeutic efficacy
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 enhances central carbon metabolism and relevant metabolism in colorectal cancer cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 enhances central carbon metabolism and relevant metabolism in colorectal cancer cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S12 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
Gαq is essential for GPR15 machinery-mediated metabolic reprogramming and the enhancement of 5-FU efficacy
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S12 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
Gαq is essential for GPR15 machinery-mediated metabolic reprogramming and the enhancement of 5-FU efficacy
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
G protein–coupled receptors (GPCR) are increasingly recognized for their organelle-specific functions in cancer. A better understanding of the mechanisms governing their dynamic subcellular distribution and functional coordination is essential for developing spatially targeted therapies that exploit the subcellular signaling networks of GPCRs. In this study, we found that Golgi-localized GPR15 underwent spatiotemporal trafficking to enhance 5-fluorouracil (5-FU) chemosensitivity in colorectal cancer. Dependent on Gαq, GPR15 associated with and restrained PARP4 enzymatic activity in the Golgi apparatus to drive cytosolic NAD+ accumulation. MGST1 interacted with and navigated GPR15 redistribution to mitochondria to increase mitochondrial NAD+ abundance, which fueled central carbon metabolism and activated downstream metabolic networks to prime tumors for 5-FU cytotoxicity. Treatment with the PARP inhibitor rucaparib showed potent synergy with 5-FU and demonstrated robust tumor suppression in patient-derived organoids and xenograft models through NAD+-mediated metabolic perturbation. This work establishes spatially encoded GPCR signaling as a druggable axis to potentiate chemotherapy efficacy, redefining intracellular receptor trafficking as an important regulator of metabolic plasticity in cancer therapy.Significance:GPCR redistribution spatially regulates NAD+ metabolism and can be harnessed with clinically available PARP inhibitors to enhance chemosensitivity, offering a strategy to target nongenetic adaptive mechanisms for treating colorectal cancer.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
G protein–coupled receptors (GPCR) are increasingly recognized for their organelle-specific functions in cancer. A better understanding of the mechanisms governing their dynamic subcellular distribution and functional coordination is essential for developing spatially targeted therapies that exploit the subcellular signaling networks of GPCRs. In this study, we found that Golgi-localized GPR15 underwent spatiotemporal trafficking to enhance 5-fluorouracil (5-FU) chemosensitivity in colorectal cancer. Dependent on Gαq, GPR15 associated with and restrained PARP4 enzymatic activity in the Golgi apparatus to drive cytosolic NAD+ accumulation. MGST1 interacted with and navigated GPR15 redistribution to mitochondria to increase mitochondrial NAD+ abundance, which fueled central carbon metabolism and activated downstream metabolic networks to prime tumors for 5-FU cytotoxicity. Treatment with the PARP inhibitor rucaparib showed potent synergy with 5-FU and demonstrated robust tumor suppression in patient-derived organoids and xenograft models through NAD+-mediated metabolic perturbation. This work establishes spatially encoded GPCR signaling as a druggable axis to potentiate chemotherapy efficacy, redefining intracellular receptor trafficking as an important regulator of metabolic plasticity in cancer therapy.Significance:GPCR redistribution spatially regulates NAD+ metabolism and can be harnessed with clinically available PARP inhibitors to enhance chemosensitivity, offering a strategy to target nongenetic adaptive mechanisms for treating colorectal cancer.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 deficiency results in metabolic reprogramming in colorectal cancer cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 deficiency results in metabolic reprogramming in colorectal cancer cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 promotes 5-FU induced apoptosis and reduced proliferation
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 promotes 5-FU induced apoptosis and reduced proliferation
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 modulates NAD and NADH abundance
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
GPR15 modulates NAD and NADH abundance
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
Golgi-localized GPR15 associates with PARP4 and modulation of NAD abundance
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
Golgi-localized GPR15 associates with PARP4 and modulation of NAD abundance
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S15 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
Rucaparib and 5-FU present similar metabolic reprogramming
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S15 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
Rucaparib and 5-FU present similar metabolic reprogramming
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S13 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
ScRNA-seq mining analysis of colorectal pathological tissues compared to normal tissues
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S13 from Subcellular Redistribution of Endomembrane GPR15 Promotes NAD+-Mediated Metabolic Reprogramming and Boosts 5-FU Chemosensitivity in Colorectal Cancer
ScRNA-seq mining analysis of colorectal pathological tissues compared to normal tissues